docetaxel anhydrous has been researched along with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) | Trials (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) | Recent Studies (post-2010) (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 131 | 26 | 70 |
Protein | Taxonomy | docetaxel anhydrous (IC50) | 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (IC50) |
---|---|---|---|
Ribonucleoside-diphosphate reductase subunit M2 | Homo sapiens (human) | 0.185 | |
CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | 9.078 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Erdogan, S; Serttas, R | 1 |
1 other study(ies) available for docetaxel anhydrous and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone
Article | Year |
---|---|
Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant Prostate Cancer Cells.
Topics: Apoptosis; Cell Line, Tumor; Docetaxel; Endoplasmic Reticulum Stress; Humans; Male; Prostatic Neoplasms; Ribonucleotide Reductases | 2023 |